Guide for patients & caregivers

TI-RADS 5 Thyroid Nodule: What Does It Mean and What Happens Next?

A TI-RADS 5 thyroid nodule explained: what TR5 means, when FNA biopsy is advised, how Bethesda biopsy results are reported, and questions to ask your team.

By SameCase EditorialUpdated 6 min read

Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles

What does a TI-RADS 5 thyroid nodule mean?

A TI-RADS 5 (TR5) thyroid nodule is one that scored 7 or more points on the American College of Radiology (ACR) ultrasound system, the highest of its five levels. Under ACR criteria, FNA biopsy is recommended if the nodule is 1 cm or larger, and yearly follow-up ultrasound for 5 years if it measures 0.5 to 0.9 cm.

It is natural to feel worried by the highest score. TR5 means the ultrasound showed several features that, together, deserve a closer look. It does not mean cancer has been found. Cleveland Clinic explains that a biopsy helps find out what caused a nodule, and the result of that biopsy matters much more than the score.

This guide is for adults reading an existing thyroid ultrasound report or waiting for biopsy results. It explains the terms so you can prepare questions. It cannot interpret your scan or predict your result. If your report says TR3, the separate TI-RADS 3 guide covers that level.

Symptoms that need earlier care

Many people with a TR5 nodule have no symptoms. The NHS advises seeing a GP or your own clinician for a neck lump, a hoarse voice that is not getting better, difficulty swallowing that is not getting better, or pain or a pressing feeling in the front of the neck. Mention any of these to your team rather than waiting for a planned appointment.

The NHS advises asking for urgent help if you are having difficulty breathing. If breathing becomes severely difficult, use local emergency services. After a biopsy, Cleveland Clinic advises contacting your provider about fever, chills, or redness, swelling or pus at the biopsy site.

Why does a nodule score TI-RADS 5?

ACR TI-RADS adds points for five ultrasound features: composition, echogenicity (how bright or dark the nodule looks), shape, margins and echogenic foci, which include some types of calcification. In the ACR reporting template, 4 to 6 points is TR4, and 7 or more is TR5.

Several routes lead to TR5. For example, the template gives 2 points for a solid nodule, 3 for a very hypoechoic (very dark) one and 3 for a taller-than-wide shape, which totals 8. Punctate echogenic foci and lobulated or irregular margins also add points. Your report should list each feature, so you can see how the total was reached.

TI-RADS 5 size thresholds: when is FNA advised?

The ACR template sets these recommendations by category and maximum size. Your clinician may advise a different plan based on your history or other findings.

  • TR5, 1 cm or larger: ultrasound-guided fine-needle aspiration (FNA) biopsy is recommended.
  • TR5, 0.5 to 0.9 cm: follow-up ultrasound every year for 5 years.
  • TR5, under 0.5 cm: the ACR chart sets no FNA or follow-up threshold for this size.
  • Significant growth, in the template's terms: an increase of 20% or more in two dimensions, with a minimum increase of 2 mm.

What happens during a thyroid FNA biopsy?

Cleveland Clinic describes FNA as an outpatient procedure that takes about 10 to 20 minutes. The neck is numbed with local anaesthetic, ultrasound guides a thin needle into the nodule, and a small sample of cells and fluid is drawn out. You need to keep very still while the sample is taken.

Soreness and bruising are common afterwards. Complications such as bleeding or infection are rare. Ask the team in advance about any medicines you take, especially blood thinners, but do not stop or change a prescribed medicine unless the prescriber or biopsy team tells you to.

What do Bethesda results mean after a TR5 nodule?

The cells are examined under a microscope. Many laboratories report the result using the Bethesda System for Reporting Thyroid Cytopathology, which has six categories, each with its own suggested management. Cleveland Clinic and the American Thyroid Association describe what each usually leads to. In the UK, results may instead be reported as Thy1 to Thy5, as Cancer Research UK explains.

  • Bethesda 1, non-diagnostic: not enough cells to give an answer. A repeat biopsy is often needed.
  • Bethesda 2, benign: the nodule is non-cancerous. Follow-up ultrasound is usual, and another biopsy may be needed if the nodule grows.
  • Bethesda 3, atypia of undetermined significance (AUS): the cells cannot be classified clearly. Repeat FNA, molecular tests or surgery may be discussed.
  • Bethesda 4, follicular neoplasm: the answer can only be made by removing the nodule, and often only the affected side of the thyroid is removed.
  • Bethesda 5, suspicious for malignancy: the American Thyroid Association says this result usually leads to surgery after discussion with the endocrinologist and surgeon. Cleveland Clinic notes molecular testing may also be considered.
  • Bethesda 6, malignant: cancer cells are seen, and surgery is almost always advised.

What are the next steps after the result?

The NHS says test results usually take about 2 weeks, sometimes longer, and that a delay does not by itself mean anything is wrong. A specialist will explain what the result means. You can bring someone with you to that appointment.

If the result is unclear, the American Thyroid Association says molecular tests on the biopsy sample can be particularly helpful. If cancer is diagnosed, the NHS explains that more tests, such as a CT, MRI or PET scan or a camera check of the vocal cords, may be used to plan treatment, and a clinical nurse specialist is usually the main contact. The American Thyroid Association notes that most thyroid cancers are curable and rarely cause life-threatening problems.

Questions to ask your clinician

Bring the full ultrasound report, the biopsy report if you have it, and any earlier scans.

  • Which features added up to my TR5 score, and does the report use ACR TI-RADS?
  • Based on the size, is FNA or follow-up scanning advised, and does my history change that?
  • Which Bethesda (or Thy) category is my biopsy result, and what does it mean for me?
  • If the result is unclear, would a repeat biopsy or molecular test help?
  • If surgery is suggested, how much of the thyroid would be removed, and why?
  • Who will contact me with results, and when?

How can similar cases help you prepare?

On SameCase, patients and verified doctors share de-identified cases. Reading how others with a TR5 nodule moved from ultrasound to biopsy result can show which questions they asked and which details mattered, such as the Bethesda category or a repeat biopsy.

Other people's cases cannot tell you what your nodule is or what your result will be. Use them to prepare questions, then discuss those questions with the team who has your full reports and history.

Sources and further reading

For patients & caregivers

Share your case and learn from others

Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.

Keep learning